SlideShare a Scribd company logo
1 of 3
Annex “A”
Professional Regulation Commission
INFORMED CONSENT
ON THE POTENTIAL RISK ASSOCIATED WITH TAKING THE
LICENSURE EXAMINATION
(profession)
PLEASE READ THIS DOCUMENT CAREFULLY.
You are given this informed consent form because the Professional Regulation
Commission (PRC) and Professional Regulatory Board of _____________________
(profession)
encourage your participation in the _____________licensure examination. All known
(profession)
precautions are taken to safeguard all examinees, but the PRC/PRB cannot
guarantee your absolute safety from any potential source of infection. You are asked
to sign this form to signify your consent to participate in the said activity despite the
potential risks.
INFORMATION SHEET
Introduction and Purpose of the Activity
On March 11, 2020, the World Health Organization (WHO) has declared COVID-19
a pandemic with confirmed cases nearing twenty million (20,000,000) around the
world without yet any sign of decline. The Philippines was no exception. With the
continuing upsurge of recorded cases per day, the country needs to reinforce the
number of its health workers to fight this pandemic.
Following the request of different professional organization and other stakeholders,
the Commission is prepared, although with greater precaution this time, to discharge
its mandate of conducting the licensure examinations.
Procedure
The PRC are instituting health safety protocols to ensure the safety of all examinees,
as well as the PRC personnel involved in the conduct of the examination. Listed
below are the established best practices and their respective percentages of risk
reduction of COVID-19 transmission:
• 95% if you use N95 mask, 76% for surgical mask
• 67% if you wear face shield
• 90% if there is distance of 1 meter, 92% if 2 meters
(For a more detailed information, please refer to PRC Memorandum Order No. ____
s. 2020 entitled “STRICT HEALTH PROTOCOLS TO BE OBSERVED IN THE
CONDUCT OF LICENSURE EXAMINATIONS DURING THE COVID-19
PANDEMIC”).
Risks
By participating in the examination, it is possible that you will be exposed to COVID-
19. There is, for example, a chance that you might contract the virus while
transporting to the venue. Although reduced in number with the mandatory minimum
distances between examinees, you will still be staying in an enclosed room together
with other examinees for several hours. Nonetheless, we assure you that the PRC
will implement all known safety measures prescribed by the Omnibus Guidelines of
the Inter-Agency Task Force (IATF) and the recommendations of the scientific
community to reduce the possibility of infection.
You still have the responsibility to weigh the risks against the benefits. Your
judgment and discernment will guide you in deciding whether to take the licensure
examination or not.
Alternative to Participating in the licensure examination
As a rule, all examinees who fail to take the licensure examination will be considered
absent and need to be re-apply and pay for the next exam. By way of exemption, if
you fail to participate in the examination because of health reasons, travel
restrictions or any other valid reasons, please inform the concerned Regional Office
of your place of examination within the week prior to the exam. You will be allowed to
take the next scheduled licensure examination, provided that the requirements
mentioned herein are complied with.
Post Examination Requirement
Fifteen (15) days, after the examination, we require the examinees to submit a post-
exam health status update (Annex C) to help the examinees and future conduct of
licensure examinations. The form can be downloaded from the website
(www.prc.gov.ph) and this can be sent through the official email address of the
Regional Office where you take your licensure examination. Please provide the
information as accurately as possible.
Agreement to Participate: If you agree to participate in the licensure examination,
please indicate so by signing on the specified space below.
Thank you.
CERTIFICATE OF CONSENT
I, ___________________________________, of legal age, residing at ___________
(Last Name, First Name Middle Name)
___________________________________________ have read and understood
the
(Address)
information and the potential health risks explained in this form. Despite such risks, I
agree to take the___________________________________ Licensure Examination
(Prof ession)
on __________________________________ to be administered by the Professional
(Date/s of Examination)
Regulation Commission. I do hereby confirm and declare that I am participating in
this event on my own free will and volition.
In relation thereto, I hold PRC, entirely free from any liability or responsibility in the
event that I contract COVID-19 during the period of the Licensure Examination on
__________________________.
(Date/s of Examination)
________________________________ _____________
Name of Examinee and Signature Date
________________________________ _____________
Name of Witness and Signature Date

More Related Content

Similar to 2020 68 annex a - informed consent101620 (1)

pfizer-inc-covid-19-vaccine-contract.pdf
pfizer-inc-covid-19-vaccine-contract.pdfpfizer-inc-covid-19-vaccine-contract.pdf
pfizer-inc-covid-19-vaccine-contract.pdf
Aurorasa Coaching
 
10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf
10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf
10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf
Bouchaib7
 
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
ijcax
 
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...
Takuji Shimomura
 
18Compliance PoliciesNameCourse Professor
18Compliance PoliciesNameCourse Professor18Compliance PoliciesNameCourse Professor
18Compliance PoliciesNameCourse Professor
AnastaciaShadelb
 
OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...
OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...
OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...
Prof. Marcus Renato de Carvalho
 

Similar to 2020 68 annex a - informed consent101620 (1) (20)

law of uaeon medical products
law of uaeon medical productslaw of uaeon medical products
law of uaeon medical products
 
Access bio care antigen US=FDA EUA Approvel Letter
Access bio care antigen US=FDA EUA Approvel LetterAccess bio care antigen US=FDA EUA Approvel Letter
Access bio care antigen US=FDA EUA Approvel Letter
 
A Survey on Current Applications for Tracking COVID-19
A Survey on Current Applications for Tracking COVID-19A Survey on Current Applications for Tracking COVID-19
A Survey on Current Applications for Tracking COVID-19
 
South Africa reaches its first vaccination milestone early
South Africa reaches its first vaccination milestone early South Africa reaches its first vaccination milestone early
South Africa reaches its first vaccination milestone early
 
Pharmacovigilance Department Initiatives During COVID-19
Pharmacovigilance Department Initiatives During COVID-19Pharmacovigilance Department Initiatives During COVID-19
Pharmacovigilance Department Initiatives During COVID-19
 
pfizer-inc-covid-19-vaccine-contract.pdf
pfizer-inc-covid-19-vaccine-contract.pdfpfizer-inc-covid-19-vaccine-contract.pdf
pfizer-inc-covid-19-vaccine-contract.pdf
 
pfizer-inc-covid-19-vaccine-contract.pdf
pfizer-inc-covid-19-vaccine-contract.pdfpfizer-inc-covid-19-vaccine-contract.pdf
pfizer-inc-covid-19-vaccine-contract.pdf
 
10 rtgn
10 rtgn10 rtgn
10 rtgn
 
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATIONCDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
CDSCO- CENTRAL DRUG STANDARD CONTROL ORGANISATION
 
Guidelines for ultrasound establishment s during the covid 19 pandemic
Guidelines for ultrasound establishment s during the covid 19 pandemicGuidelines for ultrasound establishment s during the covid 19 pandemic
Guidelines for ultrasound establishment s during the covid 19 pandemic
 
10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf
10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf
10152 Manual on COVID-19 Cross-border Risk Management 3rd Ed.pdf
 
Module 1-Covid 19 policy
Module 1-Covid 19 policyModule 1-Covid 19 policy
Module 1-Covid 19 policy
 
Increasing Patient Fraud- Health 2.0 Conference Reviews Healthcare Providers’...
Increasing Patient Fraud- Health 2.0 Conference Reviews Healthcare Providers’...Increasing Patient Fraud- Health 2.0 Conference Reviews Healthcare Providers’...
Increasing Patient Fraud- Health 2.0 Conference Reviews Healthcare Providers’...
 
WHO-EURO-2022-4724-44487-62944-eng.pdf
WHO-EURO-2022-4724-44487-62944-eng.pdfWHO-EURO-2022-4724-44487-62944-eng.pdf
WHO-EURO-2022-4724-44487-62944-eng.pdf
 
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
 
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-1...
 
FDA Guidance on Conduct of Clinical Trials of Medical Products during Covid-1...
FDA Guidance on Conduct of Clinical Trials of Medical Products during Covid-1...FDA Guidance on Conduct of Clinical Trials of Medical Products during Covid-1...
FDA Guidance on Conduct of Clinical Trials of Medical Products during Covid-1...
 
Telehealth Beyond-covid
Telehealth Beyond-covidTelehealth Beyond-covid
Telehealth Beyond-covid
 
18Compliance PoliciesNameCourse Professor
18Compliance PoliciesNameCourse Professor18Compliance PoliciesNameCourse Professor
18Compliance PoliciesNameCourse Professor
 
OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...
OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...
OMS / Código 2020 - Relatório sobre a Comercialização de Substitutos do Leite...
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 

2020 68 annex a - informed consent101620 (1)

  • 1. Annex “A” Professional Regulation Commission INFORMED CONSENT ON THE POTENTIAL RISK ASSOCIATED WITH TAKING THE LICENSURE EXAMINATION (profession) PLEASE READ THIS DOCUMENT CAREFULLY. You are given this informed consent form because the Professional Regulation Commission (PRC) and Professional Regulatory Board of _____________________ (profession) encourage your participation in the _____________licensure examination. All known (profession) precautions are taken to safeguard all examinees, but the PRC/PRB cannot guarantee your absolute safety from any potential source of infection. You are asked to sign this form to signify your consent to participate in the said activity despite the potential risks. INFORMATION SHEET Introduction and Purpose of the Activity On March 11, 2020, the World Health Organization (WHO) has declared COVID-19 a pandemic with confirmed cases nearing twenty million (20,000,000) around the world without yet any sign of decline. The Philippines was no exception. With the continuing upsurge of recorded cases per day, the country needs to reinforce the number of its health workers to fight this pandemic. Following the request of different professional organization and other stakeholders, the Commission is prepared, although with greater precaution this time, to discharge its mandate of conducting the licensure examinations. Procedure The PRC are instituting health safety protocols to ensure the safety of all examinees, as well as the PRC personnel involved in the conduct of the examination. Listed below are the established best practices and their respective percentages of risk reduction of COVID-19 transmission: • 95% if you use N95 mask, 76% for surgical mask
  • 2. • 67% if you wear face shield • 90% if there is distance of 1 meter, 92% if 2 meters (For a more detailed information, please refer to PRC Memorandum Order No. ____ s. 2020 entitled “STRICT HEALTH PROTOCOLS TO BE OBSERVED IN THE CONDUCT OF LICENSURE EXAMINATIONS DURING THE COVID-19 PANDEMIC”). Risks By participating in the examination, it is possible that you will be exposed to COVID- 19. There is, for example, a chance that you might contract the virus while transporting to the venue. Although reduced in number with the mandatory minimum distances between examinees, you will still be staying in an enclosed room together with other examinees for several hours. Nonetheless, we assure you that the PRC will implement all known safety measures prescribed by the Omnibus Guidelines of the Inter-Agency Task Force (IATF) and the recommendations of the scientific community to reduce the possibility of infection. You still have the responsibility to weigh the risks against the benefits. Your judgment and discernment will guide you in deciding whether to take the licensure examination or not. Alternative to Participating in the licensure examination As a rule, all examinees who fail to take the licensure examination will be considered absent and need to be re-apply and pay for the next exam. By way of exemption, if you fail to participate in the examination because of health reasons, travel restrictions or any other valid reasons, please inform the concerned Regional Office of your place of examination within the week prior to the exam. You will be allowed to take the next scheduled licensure examination, provided that the requirements mentioned herein are complied with. Post Examination Requirement Fifteen (15) days, after the examination, we require the examinees to submit a post- exam health status update (Annex C) to help the examinees and future conduct of licensure examinations. The form can be downloaded from the website (www.prc.gov.ph) and this can be sent through the official email address of the Regional Office where you take your licensure examination. Please provide the information as accurately as possible. Agreement to Participate: If you agree to participate in the licensure examination, please indicate so by signing on the specified space below. Thank you.
  • 3. CERTIFICATE OF CONSENT I, ___________________________________, of legal age, residing at ___________ (Last Name, First Name Middle Name) ___________________________________________ have read and understood the (Address) information and the potential health risks explained in this form. Despite such risks, I agree to take the___________________________________ Licensure Examination (Prof ession) on __________________________________ to be administered by the Professional (Date/s of Examination) Regulation Commission. I do hereby confirm and declare that I am participating in this event on my own free will and volition. In relation thereto, I hold PRC, entirely free from any liability or responsibility in the event that I contract COVID-19 during the period of the Licensure Examination on __________________________. (Date/s of Examination) ________________________________ _____________ Name of Examinee and Signature Date ________________________________ _____________ Name of Witness and Signature Date